[The Synergistic Anti-Leukemia Effect of Bcl-2 Inhibitor Combined with HDAC Inhibitor by PI3K/AKT/FoxO1 Axis in T-Cell Acute Lymphoblastic Leukemia]
{{output}}
Objective: To investigate the mechanism of the synergistic anti-leukemia effect of the combination of Bcl-2 inhibitor venetoclax (VEN) and histone deacetylase (HDAC) inhibitor chidamide (CDM) in T-cell acute lymphoblastic leukemi... ...
